USC logo
University of Southern California
PIBBS Online ApplicationPIBBS CalendarContact PIBBSPIBBS Faculty DirectoryPIBBS Site Index
PIBBS Home PageFaculty ResearchFaculty DirectoryPhD ProgramsOnline Application
Research Centers and Institutes Faculty Research Support Seminars and Symposia PIBBS Faculty in the News


Michael R. Lieber

Professor

Pathology, Biochemistry & Molecular Biology, Molecular Microbiology & Immunology, Biological Sciences
USC / Norris Comprehensive Cancer Center
Keck School of Medicine
College of Letters Arts & Sciences

Send E-mail to:   lieber@usc.edu 
Telephone: 323-865-0568Fax: 323-865-3019
Office: NOR 5428Mail Code: 9176 HSC

Education:
BS 1977 Biology- University of Missouri, Columbia, MO
BA 1977 Biochemistry- University of Missouri, Columbia,MO
PhD 1981 Biochemistry- University of Chicago,IL
MD 1983 Medicine- University of Chicago,IL

Postdoctoral Research Fellowship:
1983-1989 National Institute of Health,Bethesda,Maryland

Started at USC: 1997

Research Topics: Cancer Genetics, Aging, DNA & RNA, Protein Chemistry/Enzymology, Immunology, Epigenetics, Structural Biology

Click here for:PubMed SearchNIH GrantsResearch KeywordsSearch USC for Professor Lieber

See also:     All USC Research GrantsAll HSC Research Grants

USC News Story:   ETCETERA

USC News Story:   Etcetera

USC News Story:   Jump-Starting New Directions in Research

USC News Story:   Keck School faculty panel shares tips with M.D./Ph.D. students on choosing a residency

     See Also:      All PIBBS Faculty in the News

Research Description

        DNA double-strand breaks occur as part of the physiologic development of the immune repertoire in B and T lymphocytes. We study the manner in which these breaks are generated in a process called V(D)J recombination. Defects in the normal enzymes that generate these breaks can result in inherited forms of human severe combined immune deficiency (SCID). We study the biochemistry of how these proteins function, and we study how mutations in them result in SCID. Once DNA breaks are generated, they must be repaired. All cells of the body possess the ability to repair double-strand DNA breaks because all cells must deal with pathologic breaks in DNA that arise due to external radiation or due to free radicals of oxidative metabolism. The major pathway for repairing double-strand breaks in mammalian cells is called nonhomologous DNA end joining (NHEJ). If this pathway is defective in lymphocytes, then the breaks generated can not be repaired. Such defects also result in SC ID. If the NHEJ pathway is defectve in all cells of the body, not only is the immune system affected, but the entire body is extremely vulnerable to ionizing radiation. Our laboratory has made substantial progress in defining proteins important in the NHEJ pathway. The first protein in the NHEJ pathway, Ku, binds at the broken DNA ends. The Artemis:DNA-PKcs complex is recruited to the DNA end by Ku. This binding activates the protein kinase activity of DNA-PKcs, which then phosphorylates Artemis and makes the Artemis:DNA-PKcs complex a potent nuclease for trimming DNA ends. Polymerase mu and lambda fill-in gaps, and polymerase mu can add nucleotides template-indepenently, like TdT. Finally, DNA ligase IV, XRCC4, and XLF form the ligation complex which ligates the double-strand break. We are interested in how all of these proteins carry out their functions and how their structure is important for this, and we are interested in identifying any other proteins that might be in th is pathway. We are also interested in how chromatin structure affects these proteins as they repair DNA breaks. The process of NHEJ is intrinsically imprecise. We suspect that this imprecision may contribute to the aging of somatic cells over time as well as to cancer. We are currently investigating this possibility using cell culture models, animal models, and analysis of human cells. Identification of inhibitors of NHEJ would be useful in cancer therapy and in improving gene targeting in human stem cells, and hence, we are trying to identify inhibitors of the pathway and individual components.

        Mistakes of V(D)J recombination account for about 40% of nonHodgkin's lymphoma. We study how the normal V(D)J recombination process goes awry. Specifically, why do some ends fail to join properly, and why do some sites adjacent to oncogenes get cleaved inadvertently. The inadvertent cleavage of some sites may be due to an altered DNA structure at those sites. We are trying to understand the extent to which such DNA structural deviations contribute to the fragility of such common chromosomal translocation hotspots.

        Class switch recombination is a second developmentally programmed gene rearrangement process in the vertebrate immune system, and it occurs in B cells at the Ig heavy chain locus. Class switching is the process that results in IgM being converted to IgG, IgA, or IgE. Humans borne with defects in class switching die early in life because they can not make IgA for protection of their lungs. The enzyme that initiates the class switch gene rearrangement process is a cytidine deaminase, called AID, that only functions on single-stranded DNA. We have focused on how the class switch recombination regions become single-stranded. Upon transcription, the RNA remains associated with the template DNA strand, resulting in an R-loop structure. The R-loop structure provides a substantial amount of single-stranded DNA at which the AID enzyme can act. We are interested in determining the factors that favor R-loop formation. In some lymphomas, the class switch recombination process goes awry, just as in V(D)J recombination. We are also studying these events.

        In summary, the Lieber lab focuses on how physiologic and pathologic gene rearrangements function in the immune system and in cancer and aging.




Selected Publications

Heo K, Kim H, Choi SH, Choi J, Kim K, Gu J, Lieber MR, Yang AS, An W. - FACT-Mediated Exchange of Histone Variant H2AX Regulated by Phosphorylation of H2AX and ADP-Ribosylation of Spt16. - Mol Cell [ 2008 ] Apr 11;30(1):86-97 . PubMed

Shimazaki N, Lieber MR. - DNA-PKcs at 7A: Insights for DNA Repair. - Structure [ 2008 ] Mar;16(3):334-6 . PubMed

Gu J, Lieber MR. - Mechanistic flexibility as a conserved theme across 3 billion years of nonhomologous DNA end-joining. - Genes Dev [ 2008 ] Feb 15;22(4):411-5 . PubMed

Lieber MR, Lu H, Gu J, Schwarz K. - Flexibility in the order of action and in the enzymology of the nuclease, polymerases, and ligase of vertebrate non-homologous DNA end joining: relevance to cancer, aging, and the immune system. - Cell Res [ 2008 ] Jan;18(1):125-33 . PubMed

Lieber MR. - The mechanism of human nonhomologous DNA end joining. - J Biol Chem [ 2008 ] Jan 4;283(1):1-5 . PubMed

Roy D, Yu K, Lieber MR. - Mechanism of R-loop formation at immunoglobulin class switch sequences. - Mol Cell Biol [ 2008 ] Jan;28(1):50-60 . PubMed

Lu H, Schwarz K, Lieber MR. - Extent to which hairpin opening by the Artemis:DNA-PKcs complex can contribute to junctional diversity in V(D)J recombination. - Nucleic Acids Res [ 2007 ] 35(20):6917-23 . PubMed

Gu J, Lu H, Tsai AG, Schwarz K, Lieber MR. - Single-stranded DNA ligation and XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: influence of terminal DNA sequence. - Nucleic Acids Res [ 2007 ] 35(17):5755-62 . PubMed

Huang FT, Yu K, Balter BB, Selsing E, Oruc Z, Khamlichi AA, Hsieh CL, Lieber MR. - Sequence dependence of chromosomal R-loops at the immunoglobulin heavy-chain Smu class switch region. - Mol Cell Biol [ 2007 ] Aug;27(16):5921-32 . PubMed

Raghavan SC, Lieber MR. - DNA structure and human diseases. - Front Biosci [ 2007 ] May 1;12:4402-8 . PubMed


NCBI Disclaimers and copyright notice
Last updated: Mon Jun 30 16:26:29 2008

Return to   PIBBS home page  |  Research Topics page
  For more information contact the PIBBS Program

University of Southern California
1975 Zonal Avenue KAM-B16
Los Angeles, California 90089-9031
323-442-1609 (voice) / 323-442-1199 (fax)
E-mail: pibbs@usc.edu
 
 
© 1998-2008 The University of Southern California
 ..